News | August 23, 2024
Sun Pharma introduces STARIZO in India for skin infections
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Sun Pharma has obtained rights from MSD to develop, manufacture and commercialise Tedizolid Phosphate in India
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
SUPERNOVA is a large Phase III global trial providing the only efficacy data in immunocompromised patients
The joint venture will help JV Partners combine their strengths and grow their complementary nutraceuticals portfolios
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
Prior to joining Alembic, he was working with Lupin Limited for more than 11 years
AHH will make an investment of Rs. 600 crore in the company through a mix of primary and secondary infusion
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
Subscribe To Our Newsletter & Stay Updated
